elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q31019795-8D0FA161-96BB-487D-94E4-87DD7194FD20
Q31019795-8D0FA161-96BB-487D-94E4-87DD7194FD20
BestRank
Statement
http://www.wikidata.org/entity/statement/Q31019795-8D0FA161-96BB-487D-94E4-87DD7194FD20
Clinical effectiveness of CT-P13 (Infliximab biosimilar) used as a switch from Remicade (infliximab) in patients with established rheumatic disease. Report of clinical experience based on prospective observational data.
P2860
Q31019795-8D0FA161-96BB-487D-94E4-87DD7194FD20
BestRank
Statement
http://www.wikidata.org/entity/statement/Q31019795-8D0FA161-96BB-487D-94E4-87DD7194FD20
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
6a74668ab9b02c39eee6dd8eb347dcd5e2526fd4
P2860
A randomised, double-blind, multicentre, parallel-group, prospective study comparing the pharmacokinetics, safety, and efficacy of CT-P13 and innovator infliximab in patients with ankylosing spondylitis: the PLANETAS study